Socioeconomic disparities in survival after high-risk neuroblastoma treatment with modern therapy.

Survival disparities among children with high-risk neuroblastoma have not widened over time, suggesting equitable access to and benefit from therapeutic advances. However, children of low SES experience persistently inferior survival. Interventions to narrow this disparity are paramount.